A Phase II, Randomized Double Blind Placebo-Controlled, Dose Escalating Study to Determine Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients
Latest Information Update: 05 Nov 2021
At a glance
- Drugs MTR 104 (Primary)
- Indications Hypotension
- Focus Pharmacodynamics; Pharmacokinetics
- 28 Feb 2017 New trial record